These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16162303)

  • 1. Borderline resectable pancreatic cancer.
    Varadhachary GR; Tamm EP; Crane C; Evans DB; Wolff RA
    Curr Treat Options Gastroenterol; 2005 Oct; 8(5):377-84. PubMed ID: 16162303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative therapies for resectable and borderline resectable pancreatic cancer.
    Varadhachary GR
    J Gastrointest Oncol; 2011 Sep; 2(3):136-42. PubMed ID: 22811843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.
    Varadhachary GR; Tamm EP; Abbruzzese JL; Xiong HQ; Crane CH; Wang H; Lee JE; Pisters PW; Evans DB; Wolff RA
    Ann Surg Oncol; 2006 Aug; 13(8):1035-46. PubMed ID: 16865597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement.
    Tucker ON; Rela M
    HPB Surg; 2008; 2008():839503. PubMed ID: 19283083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery.
    Barnes CA; Chavez MI; Tsai S; Aldakkak M; George B; Ritch PS; Dua K; Clarke CN; Tolat P; Hagen C; Hall WA; Erickson BA; Evans DB; Christians KK
    Surgery; 2019 Sep; 166(3):277-285. PubMed ID: 31272811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program.
    Bleeker JS; Sumey CJ; Powell SF; Steen PD; Keppen MD; Lohr M; Thambi-Pillai T; Kurniali P; Mazurczak M; Gitau MM; Blanchard MJ; Nowak RK; McGraw S; Sticca R; Tuvin D; Timmerman G
    Surg Open Sci; 2020 Oct; 2(4):25-31. PubMed ID: 32954245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy.
    Javed AA; Wright MJ; Siddique A; Blair AB; Ding D; Burkhart RA; Makary M; Cameron JL; Narang A; Herman J; Zheng L; Laheru D; Weiss MJ; Wolfgang C; He J
    J Gastrointest Surg; 2019 Jan; 23(1):112-121. PubMed ID: 30242644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.
    Wang G; Zhou D
    Ultrason Sonochem; 2015 Nov; 27():694-702. PubMed ID: 26113389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A replaced right hepatic artery adjacent to pancreatic carcinoma should be divided to obtain R0 resection in pancreaticoduodenectomy.
    Okada K; Kawai M; Hirono S; Miyazawa M; Shimizu A; Kitahata Y; Tani M; Yamaue H
    Langenbecks Arch Surg; 2015 Jan; 400(1):57-65. PubMed ID: 25359559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer.
    Kharofa J; Mierzwa M; Olowokure O; Sussman J; Latif T; Gupta A; Xie C; Patel S; Esslinger H; Mcgill B; Wolf E; Ahmad SA
    Am J Clin Oncol; 2019 Mar; 42(3):247-252. PubMed ID: 30724781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships.
    Dholakia AS; Hacker-Prietz A; Wild AT; Raman SP; Wood LD; Huang P; Laheru DA; Zheng L; De Jesus-Acosta A; Le DT; Schulick R; Edil B; Ellsworth S; Pawlik TM; Iacobuzio-Donahue CA; Hruban RH; Cameron JL; Fishman EK; Wolfgang CL; Herman JM
    J Radiat Oncol; 2013 Dec; 2(4):413-425. PubMed ID: 25755849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
    Katz MHG; Ou FS; Herman JM; Ahmad SA; Wolpin B; Marsh R; Behr S; Shi Q; Chuong M; Schwartz LH; Frankel W; Collisson E; Koay EJ; Hubbard JM; Leenstra JL; Meyerhardt J; O'Reilly E;
    BMC Cancer; 2017 Jul; 17(1):505. PubMed ID: 28750659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer.
    Kharofa J; Tsai S; Kelly T; Wood C; George B; Ritch P; Wiebe L; Christians K; Evans DB; Erickson B
    Radiother Oncol; 2014 Oct; 113(1):41-6. PubMed ID: 25443499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
    Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
    Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of borderline resectable pancreatic cancer.
    Mahipal A; Frakes J; Hoffe S; Kim R
    World J Gastrointest Oncol; 2015 Oct; 7(10):241-9. PubMed ID: 26483878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.
    Brown KM; Siripurapu V; Davidson M; Cohen SJ; Konski A; Watson JC; Li T; Ciocca V; Cooper H; Hoffman JP
    Am J Surg; 2008 Mar; 195(3):318-21. PubMed ID: 18308038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.
    Stokes JB; Nolan NJ; Stelow EB; Walters DM; Weiss GR; de Lange EE; Rich TA; Adams RB; Bauer TW
    Ann Surg Oncol; 2011 Mar; 18(3):619-27. PubMed ID: 21213060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas.
    Mehta VK; Fisher G; Ford JA; Poen JC; Vierra MA; Oberhelman H; Niederhuber J; Bastidas JA
    J Gastrointest Surg; 2001; 5(1):27-35. PubMed ID: 11309645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior 'superior mesenteric artery first' approach for resection of locally advanced pancreatic cancer.
    Rose JB; Rocha F; Alseidi A; Helton S
    Ann Surg Oncol; 2014 Jun; 21(6):1927-8. PubMed ID: 24370905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.